TRMED Share Price Performance
NOK 4.43
1.96 (79.35%)
26.6% overvalued intrinsic discount
NOK 3.50
Fair Value
Price NOK 4.43
AnalystConsensusTarget NOK 3.50
Fair ValueNOK 3.50
Share Pricen/a
Thor Medical ASA Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
TRMED Community Narratives
AN
Fair Value
·Fair Value NOK 3.5 26.6% overvalued intrinsic discount
Alpha Emitter Capacity Ramp And Order Backlog Will Eventually Undermine This Bullish Narrative
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Alpha Emitter Capacity Ramp And Order Backlog Will Eventually Undermine This Bullish Narrative
Catalysts About Thor Medical Thor Medical focuses on producing alpha emitting isotopes for radiopharmaceutical companies using a proprietary thorium based process. What are the underlying business or industry changes driving this perspective?Read more
AN
NOK 3.5
26.6% overvalued intrinsic discount
Fair Value
Profit Margin
15.44%
Future PE
54.41x
Price in 2029
NOK 4.24
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
Alpha Emitter Capacity Ramp And Order Backlog Will Eventually Undermine This Bullish Narrative
Fair Value: NOK 3.5 26.6% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Thor Medical ASA Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 28, 2026
- -0.16
- 100.00%
- -6,914.42%
- 0%
About TRMED
- Founded
- 2009
- Employees
- 18
- CEO
- WebsiteView website
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
